MaryBoulangerMD

Thoracic Cancer

Medical Oncology Fellow

Dr. Boulanger is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

I am a third year medical oncology fellow at the Dana-Farber Cancer Institute/Massachusetts General Brigham. My career goal is to become a thoracic oncologist and clinical investigator with a focus on improving the quality of life of people with advanced cancer.

Brigham and Women's Hospital/Massachusetts General Hospital/Dana-Farber Cancer InstituteFellowship, Hematology and Medical Oncology, 2022
Johns Hopkins UniversityResidency, Internal Medicine, 2019 - 2022
University of Kentucky College of MedicineClass of 2019

PubMed

Patient and Caregiver Experience With the Hope and Prognostic Uncertainty of Immunotherapy: A Qualitative Study.
Mary C Boulanger, Ayo S Falade, Kelly Hsu, Robert K Sommer, Ashley Zhou
JCO Oncology Practice. 2025-02-01
1 citations
Financial toxicity in early-phase cancer clinical trial participants.
Sienna M Durbin, Debra Lundquist, Andrea Pelletier, Laura A Petrillo, Viola Bame
Cancer. 2025-01-01
2 citations
Advances and future directions in ROS1 fusion-positive lung cancer.
Mary C Boulanger, Jaime L Schneider, Jessica J Lin
The Oncologist. 2024-11-04

Journal Articles

Disparities in Telemedicine Success and Their Association with Adverse Outcomes in Patients With Thoracic Cancer During the COVID-19 Pandemic
Waseem N, Boulanger M, Yanek LR, Feliciano JL, JAMA Network Open, 7/1/2022

Books/Book Chapters

Forskolin: Sources, Mechanisms of Action and Health Effects
Chapter: UV Protection of the Skin by Topically-applied Forskolin
Amaro-Ortiz A, Boulanger MC, D’Orazio JANova Publishers2015